<--- Back to Details
First PageDocument Content
Pharmaceuticals policy / Health / Pharmaceutical industry / Pharmacology / European Medicines Agency / European Union / Marketing authorization / European Directorate for the Quality of Medicines / EudraLex / European Pharmacopoeia / Orphan drug / Supplementary protection certificate
Date: 2015-07-08 04:50:21
Pharmaceuticals policy
Health
Pharmaceutical industry
Pharmacology
European Medicines Agency
European Union
Marketing authorization
European Directorate for the Quality of Medicines
EudraLex
European Pharmacopoeia
Orphan drug
Supplementary protection certificate

emea_strap_url_cmyk_rev_en_std_cent.eps MASTER

Add to Reading List

Source URL: www.hma.eu

Download Document from Source Website

File Size: 535,20 KB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document